The Madras Diabetes Research Foundation (MDRF) has entered into a strategic research collaboration with the Almazov National Medical Research Centre, based in Saint Petersburg, Russia. This partnership marks a significant step toward advancing international research in diabetes and its related fields.
The Almazov Centre, a leading medical research institution under the Ministry of Health of the Russian Federation, and MDRF will collaborate on several key areas including the development of new diagnostics and treatment strategies for diabetes, particularly Gestational Diabetes Mellitus (GDM), as well as emerging fields such as artificial intelligence and precision medicine in diabetes care.
The MoU was formally signed by Dr V. Mohan, and Prof. Evgeny Shlyakhto, Director General of the Almazov Centre. As part of the agreement, the two institutions will engage in the training and exchange of medical specialists, joint scientific conferences and academic meetings, collaborative research publications, and the development of educational and cultural exchange programmes.
Speaking on the collaboration, Dr. V. Mohan - Chairman of MDRF said, “This partnership signifies a shared commitment to tackling one of the most pressing global health challenges—diabetes—through scientific innovation and international cooperation. We are particularly excited about the opportunity to jointly explore the potential of AI and precision medicine to transform diabetes care.”
Further to the signing of the MoU, researchers from both institutions have commenced joint projects focusing on gestational diabetes. The collaboration involves Dr Polina V. Popova and her team from the Department of Endocrinology at the Almazov Centre, and Dr Mohan and his colleagues from MDRF, with plans to expand the scope of their joint research initiatives in the coming months.
